Treatment for Pink Eye (Conjunctivitis)
Treatment depends on the underlying cause—viral conjunctivitis requires only supportive care, bacterial conjunctivitis may benefit from topical antibiotics (though often self-limited), and allergic conjunctivitis responds to topical antihistamines with mast cell stabilizers. 1, 2
Initial Diagnostic Approach
The key to appropriate treatment is distinguishing between viral, bacterial, and allergic etiologies based on specific clinical features:
Viral Conjunctivitis:
- Watery discharge with follicular reaction on inferior tarsal conjunctiva 3
- Often starts unilateral but becomes sequentially bilateral 1, 3
- Preauricular lymphadenopathy present 1, 3
- May have concurrent upper respiratory infection 1
- Subconjunctival hemorrhages and chemosis are distinctive findings 3
Bacterial Conjunctivitis:
- Mucopurulent discharge with matted eyelids upon waking 4, 5
- Papillary (not follicular) reaction 3
- Lack of itching and no history of prior conjunctivitis 4
- Preauricular lymphadenopathy less common unless hypervirulent organisms 3
Allergic Conjunctivitis:
- Itching is the most consistent and distinguishing feature 3, 4
- Bilateral presentation with watery discharge 3
- Seasonal or perennial pattern depending on allergen exposure 3
- May have concurrent allergic rhinitis or asthma 3
Treatment by Etiology
Viral Conjunctivitis
Avoid antibiotics entirely—they provide no benefit and may cause toxicity. 3
Supportive care includes:
- Artificial tears to dilute viral particles and provide comfort 2, 6
- Cold compresses to reduce inflammation 2, 6
- Topical antihistamines for itching relief 2, 6
- Oral analgesics for pain management 6
Patient education is critical:
- Minimize contact with others for 10-14 days from symptom onset in the last affected eye 2, 6
- Frequent handwashing and avoid touching eyes 6
- Use disposable towels and disinfect surfaces 3
- Avoid sharing personal items like towels and pillows 3
For severe adenoviral keratoconjunctivitis with marked chemosis, lid swelling, epithelial sloughing, or membranous conjunctivitis:
- Consider topical corticosteroids (fluorometholone, rimexolone, or loteprednol preferred) 1, 2
- Requires close ophthalmology follow-up for monitoring intraocular pressure and cataract formation 2, 6
- Taper slowly to minimum effective dose 1, 6
- Be aware corticosteroids may prolong viral shedding 3, 6
Special viral subtypes:
HSV conjunctivitis: Topical ganciclovir 0.15% gel three to five times daily OR trifluridine 1% solution five to eight times daily 1, 2
VZV conjunctivitis: Topical antibiotics to prevent secondary bacterial infection 6, 7
- Oral antivirals for persistent cases: acyclovir 800 mg five times daily for 7 days, valacyclovir 1000 mg every 8 hours for 7 days, or famciclovir 500 mg three times daily for 7 days 6
Bacterial Conjunctivitis
Mild bacterial conjunctivitis is often self-limited and resolves spontaneously in 1-2 weeks without treatment. 2, 4
For moderate to severe bacterial conjunctivitis:
- 5-7 day course of broad-spectrum topical antibiotic 2, 3
- No evidence demonstrates superiority of any particular agent—choose the most convenient or least expensive option 3
- Topical fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) are effective against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 2
- Alternative options include bacitracin ointment 1-3 times daily 7 or erythromycin ointment 8
Special considerations:
Gonococcal conjunctivitis: Requires systemic antibiotics in addition to topical therapy with daily monitoring until resolution 2, 3
Chlamydial conjunctivitis: Requires systemic treatment and evaluation of sexual partners 3, 4
- Consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 2
MRSA suspected: Consider in patients from nursing homes or with community-acquired infections 2
Allergic Conjunctivitis
Topical antihistamines with mast cell-stabilizing activity are first-line treatment. 2, 3
Environmental modifications:
- Wear sunglasses as barrier to airborne allergens 3
- Use cold compresses and refrigerated artificial tears 3
- Avoid eye rubbing 3
- Allergen avoidance strategies 3
For refractory cases:
- Short-term topical corticosteroids (1-2 week course with low side-effect profile) 3
- Baseline and periodic measurement of intraocular pressure if corticosteroids used 2
- Consider allergen-specific immunotherapy, particularly beneficial in children 3
For giant papillary conjunctivitis:
- Discontinue contact lens use in conjunction with topical anti-inflammatory agents 2
Critical Red Flags Requiring Immediate Ophthalmology Referral
Refer immediately if any of the following are present: 2, 3
- Visual loss or decreased vision
- Moderate or severe pain
- Severe purulent discharge
- Corneal involvement
- Conjunctival scarring
- Lack of response to therapy after 2-3 weeks
- Recurrent episodes
- History of HSV eye disease
- Immunocompromised state
- Neonatal conjunctivitis
- Contact lens wearers (evaluate for corneal ulcers)
- Recent ocular surgery
- Vesicular rash on eyelids or nose
Follow-Up Recommendations
For severe viral conjunctivitis:
- Re-evaluate within 1 week 3, 6
- Patients not on corticosteroids should return if symptoms persist beyond 2-3 weeks 3, 6
For patients on topical corticosteroids:
- Regular monitoring of intraocular pressure and pupillary dilation 2, 3
- Taper once inflammation is controlled 1
Common Pitfalls to Avoid
- Never use topical corticosteroids in HSV conjunctivitis without antiviral coverage—this potentiates infection 2, 3
- Avoid indiscriminate antibiotic use in viral conjunctivitis—provides no benefit and causes unnecessary toxicity 2, 3
- Do not use topical trifluridine for more than 2 weeks—causes epithelial toxicity 2
- Avoid contact lens wear during any form of infectious conjunctivitis 3
- Chronic vasoconstrictor use causes rebound conjunctival injection 3
- Delayed referral for gonococcal conjunctivitis can lead to corneal perforation 2
- Chronic/recalcitrant conjunctivitis may indicate underlying malignancy (sebaceous or squamous cell carcinoma)—requires further evaluation 3